-
Your next patient says she has a vaginal discharge. A closer examination reveals a white, noninflammatory discharge that smoothly coats the vaginal walls. What is your next step?
-
A quick check of your next patients file shows that she is returning for yet another round of treatment for trichomoniasis. The infection is not responding to standard metronidazole therapy. What is your next move?
-
Successful pill-taking is an important component for women who use oral contraceptives (OCs). Inconsistent use and method discontinuation are estimated to account for approximately 20% of the annual 3.5 million annual unintended pregnancies in the United States.
-
This month may well mark a milestone in womens health if the Food and Drug Administration (FDA) follows the recommendation of two of its expert advisory committees to approve the over-the-counter (OTC) sale of Plan B, the levonorgestrel-only emergency contraceptive (EC).
-
You are discussing contraceptive options with a patient. When you come to intrauterine devices (IUDs), she dismisses the method and says that it can lead to an ectopic pregnancy. Where did she get such misinformation?
-
-
Hardy ML. What to do about the pain of no more Vioxx? Altern Ther Women's Health 2004;6(11):85-87.
-
-
A security consulting firm that is providing security risk assessment and compliance review services for small health care related businesses says one way to increase incentives for physicians to come into compliance with HIPAA requirements would be for malpractice insurers to offer reduced premiums to those who have done a risk assessment and are moving forward on implementation.
-
The latest survey of 631 providers, payers, companies, and clearinghouses by the Healthcare Information and Management Systems Society (HIMSS) indicates that as of mid-January, only half had completed testing for the Transaction and Code Standards (TCS), which standardized what information must be contained in electronic claims and how it should be transmitted.
